Suppr超能文献

用阿尔及利亚东部传统治疗糖尿病的两种药用植物治疗 C57BL/6J 小鼠的高脂饮食诱导的 2 型糖尿病。

Treatment of high fat diet induced type 2 diabetes in C57BL/6J mice by two medicinal plants used in traditional treatment of diabetes in the east of Algeria.

机构信息

Département de Pharmacologie, Université Victor Segalen Bordeaux 2, Bordeaux, France.

出版信息

J Ethnopharmacol. 2011 Jan 27;133(2):931-3. doi: 10.1016/j.jep.2010.11.019. Epub 2010 Nov 19.

Abstract

AIM OF THE STUDY

Hydro-alcoholic extracts of Centaurium erythraea Rafn (CE), Gentianaceae and Artemisia herba-alba Asso (AHA), Asteraceae, medicinal plants used in traditional treatment of diabetes in north-eastern Algeria, were tested in established type 2 diabetes induced with a standardized high fat diet (HFD) in mice.

MATERIALS AND METHODS

After confirmation of diabetes (17th week), plant extracts were administered orally by gavage at a dose of 2 g/kg daily for 18 weeks to male C57BL/6J mice fed HFD. Animals were weighed, food intake and plasma glucose measured weekly, insulin and lipid profile at study end.

RESULTS

At 35 weeks, groups treated with AHA or CE vs. HFD control had a significant reduction in mean (±SD) fasting blood glucose concentrations (143.8±23.9 and 139.5±14.2 vs. 229.0±20.8 mg/dL, p<0.05, respectively), triglyceride (18.9±11.1 and 16.0±6.5 vs. 62.8±18.3 mg/dL, p<0.05), total cholesterol (1.2±0.1 and 1.2±0.3 vs. 1.8±1.1 g/L, p<0.05) and serum insulin concentrations (1.7±0.7 and 0.9±0.7 vs. 3.3±14.3 ng/mL, p<0.05). Plant extracts also markedly reduced insulin resistance as compared to HFD controls (AHA: 15.6±9.1, CE: 9.0±7.7 vs. HFD control 38.5±30.3, p<0.05). The plant extracts decreased calorie intake and had little effect on body weight or HDL-cholesterol.

CONCLUSION

AHA has already been shown to have a antihyperglycaemic and antihyperlipidemic effect but this is the first demonstration of an effect of AHA and CE on established HFD-induced diabetes.

摘要

研究目的

在东北阿尔及利亚,传统上用于治疗糖尿病的 Centaurium erythraea Rafn(CE)和 Artemisia herba-alba Asso(AHA)(Gentianaceae 和 Asteraceae)的水醇提取物在建立的 2 型糖尿病模型中进行了测试,该模型是由标准化高脂肪饮食(HFD)诱导的。

材料和方法

在第 17 周确认糖尿病后,将植物提取物通过灌胃以 2 g/kg 的剂量每天给药 18 周,给予喂食 HFD 的雄性 C57BL/6J 小鼠。每周测量动物体重、食物摄入量和血浆葡萄糖,在研究结束时测量胰岛素和血脂谱。

结果

在 35 周时,与 HFD 对照组相比,AHA 或 CE 治疗组的空腹血糖浓度(143.8±23.9 和 139.5±14.2 与 229.0±20.8 mg/dL,p<0.05)、甘油三酯(18.9±11.1 和 16.0±6.5 与 62.8±18.3 mg/dL,p<0.05)、总胆固醇(1.2±0.1 和 1.2±0.3 与 1.8±1.1 g/L,p<0.05)和血清胰岛素浓度(1.7±0.7 和 0.9±0.7 与 3.3±14.3 ng/mL,p<0.05)均显著降低。与 HFD 对照组相比,植物提取物还显著降低了胰岛素抵抗(AHA:15.6±9.1,CE:9.0±7.7 与 HFD 对照组 38.5±30.3,p<0.05)。植物提取物减少了热量摄入,对体重或高密度脂蛋白胆固醇几乎没有影响。

结论

AHA 已被证明具有降血糖和降血脂作用,但这是首次证明 AHA 和 CE 对已建立的 HFD 诱导的糖尿病有作用。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验